Lannett Co Inc (NYSE:LCI) CEO Arthur P. Bedrosian sold 7,422 shares of the stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $25.20, for a total transaction of $187,034.40. Following the completion of the sale, the chief executive officer now owns 679,001 shares in the company, valued at $17,110,825.20. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Shares of Lannett Co Inc (NYSE LCI) traded down $1.15 during mid-day trading on Friday, reaching $23.55. 714,663 shares of the company’s stock traded hands, compared to its average volume of 798,743. The company has a quick ratio of 2.09, a current ratio of 2.52 and a debt-to-equity ratio of 1.44. The firm has a market cap of $949.22, a P/E ratio of 9.37, a P/E/G ratio of 2.24 and a beta of 2.73. Lannett Co Inc has a 52-week low of $14.90 and a 52-week high of $27.90.

Lannett Co (NYSE:LCI) last announced its earnings results on Monday, November 6th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.52 by $0.08. The firm had revenue of $155.00 million for the quarter, compared to the consensus estimate of $153.62 million. Lannett Co had a net margin of 6.67% and a return on equity of 18.23%. The business’s quarterly revenue was down 4.1% on a year-over-year basis. During the same period last year, the company posted $0.77 EPS. sell-side analysts forecast that Lannett Co Inc will post 2.82 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Lannett Co Inc (LCI) CEO Arthur P. Bedrosian Sells 7,422 Shares” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/11/10/lannett-co-inc-lci-ceo-arthur-p-bedrosian-sells-7422-shares.html.

A number of brokerages recently weighed in on LCI. ValuEngine upgraded shares of Lannett Co from a “hold” rating to a “buy” rating in a research report on Thursday. Zacks Investment Research upgraded shares of Lannett Co from a “hold” rating to a “buy” rating and set a $28.00 price target on the stock in a research report on Friday. BidaskClub downgraded shares of Lannett Co from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 8th. Oppenheimer Holdings, Inc. restated a “hold” rating on shares of Lannett Co in a report on Wednesday, August 23rd. Finally, Deutsche Bank AG dropped their target price on shares of Lannett Co from $23.00 to $19.00 and set a “hold” rating on the stock in a report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the stock. Lannett Co has an average rating of “Hold” and a consensus price target of $22.40.

A number of hedge funds have recently made changes to their positions in the business. Wells Fargo & Company MN raised its holdings in Lannett Co by 8.1% during the 3rd quarter. Wells Fargo & Company MN now owns 41,567 shares of the company’s stock worth $767,000 after buying an additional 3,113 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Lannett Co by 296.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 306,106 shares of the company’s stock worth $5,678,000 after acquiring an additional 228,947 shares in the last quarter. Thompson Siegel & Walmsley LLC grew its stake in shares of Lannett Co by 20.5% during the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 1,010,232 shares of the company’s stock worth $18,639,000 after acquiring an additional 171,751 shares in the last quarter. Macquarie Group Ltd. grew its stake in shares of Lannett Co by 9.3% during the 3rd quarter. Macquarie Group Ltd. now owns 48,300 shares of the company’s stock worth $891,000 after acquiring an additional 4,100 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in shares of Lannett Co by 53.2% during the 3rd quarter. SG Americas Securities LLC now owns 70,667 shares of the company’s stock worth $1,304,000 after acquiring an additional 24,544 shares in the last quarter. Hedge funds and other institutional investors own 87.67% of the company’s stock.

Lannett Co Company Profile

Lannett Company, Inc develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.

Receive News & Stock Ratings for Lannett Co Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett Co Inc and related stocks with our FREE daily email newsletter.